Article
[What significance to genotype changes have in diagnosis of malignant hyperthermia?].
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS - 1 Aug 1996
Steinfath M, Scholz J, Singh S, Wappler F
Abstract excerpt
Malignant hyperthermia (MH) is a potentially fatal, inherited pharmacogenetic disorder characterised by a dysfunction of the intracellular calcium regulation. Linkage to DNA markers from the chromosome 19q12-13.2 region and the MHS-phenotype (MH susceptible) has been shown in about 50% of families with a history of MH. The ryanodine receptor gene encoding the human skeletal muscle ryanodine receptor has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
